Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
Nat Commun. 2021 Jul 7;12(1):4188. doi: 10.1038/s41467-021-24448-3.
Klebsiella pneumoniae is a leading cause of antimicrobial-resistant (AMR) healthcare-associated infections, neonatal sepsis and community-acquired liver abscess, and is associated with chronic intestinal diseases. Its diversity and complex population structure pose challenges for analysis and interpretation of K. pneumoniae genome data. Here we introduce Kleborate, a tool for analysing genomes of K. pneumoniae and its associated species complex, which consolidates interrogation of key features of proven clinical importance. Kleborate provides a framework to support genomic surveillance and epidemiology in research, clinical and public health settings. To demonstrate its utility we apply Kleborate to analyse publicly available Klebsiella genomes, including clinical isolates from a pan-European study of carbapenemase-producing Klebsiella, highlighting global trends in AMR and virulence as examples of what could be achieved by applying this genomic framework within more systematic genomic surveillance efforts. We also demonstrate the application of Kleborate to detect and type K. pneumoniae from gut metagenomes.
肺炎克雷伯菌是一种主要的抗微生物药物耐药(AMR)的医疗保健相关感染、新生儿败血症和社区获得性肝脓肿的病原体,并且与慢性肠道疾病有关。其多样性和复杂的种群结构给肺炎克雷伯菌基因组数据分析和解释带来了挑战。在这里,我们介绍 Kleborate,这是一种用于分析肺炎克雷伯菌及其相关种复合体基因组的工具,它整合了对具有临床重要性的关键特征的检测。Kleborate 为研究、临床和公共卫生环境中的基因组监测和流行病学提供了一个框架。为了展示其效用,我们应用 Kleborate 分析了公开的肺炎克雷伯菌基因组,包括来自泛欧洲产碳青霉烯酶肺炎克雷伯菌研究的临床分离株,突出了 AMR 和毒力方面的全球趋势,这些都是通过在更系统的基因组监测工作中应用这种基因组框架可以实现的。我们还展示了 Kleborate 用于从肠道宏基因组中检测和分型肺炎克雷伯菌的应用。